Adverum Biotechnologies Inc. buy Chardan Capital
Start price
19.03.24
/
50%
€1.51
Target price
19.03.25
€3.68
Performance (%)
-8.61%
Price
20.03.24
€1.38
Summary
This prediction is currently active. With a performance of -8.61%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 19.03.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Adverum Biotechnologies Inc. | - | - |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat